Abstract
The bioavailability of a pharmaceutical depends on the crystal structure of a polymorphic active ingredient or excipient. By changing the process parameters of the PGSS (Particles from Gas Saturated Solutions) process i.e. thermodynamic conditions of the solidification process it is possible to vary the crystal modification of polymorphic products. In a series of PGSS experiments microparticles of the polymorphic excipient tristearin as well as of mixtures of tristearin and the emulsifier sorbitan monolaurate were successfully produced. Pre-expansion pressure was varied between 6 and 22MPa. The effects of process dependent parameters on the crystallization were investigated via scanning electron microscopy, differential scanning calorimetry and X-ray powder diffraction.Metastable α-forms of tristearin were found immediately after the processing for all experiments. Further it was found that it is possible to shift the conversion rate of polymorphic transitions in the product either by varying the process parameters or by adding the emulsifier.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
